Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Benitec Biopharma (BNTC) Other Operating Expenses: 2019-2024

Historic Other Operating Expenses for Benitec Biopharma (BNTC) over the last 1 years, with Mar 2024 value amounting to -$3,000.

  • Benitec Biopharma's Other Operating Expenses was N/A to -$3,000 in Q1 2024 from the same period last year, while for Mar 2024 it was -$99,000, marking a year-over-year change of. This contributed to the annual value of -$108,000 for FY2024, which is N/A change from last year.
  • As of Q1 2024, Benitec Biopharma's Other Operating Expenses stood at -$3,000, which was down 400.00% from $1,000 recorded in Q4 2023.
  • Benitec Biopharma's Other Operating Expenses' 5-year high stood at $134,000 during Q3 2020, with a 5-year trough of -$106,000 in Q3 2023.
  • For the 3-year period, Benitec Biopharma's Other Operating Expenses averaged around -$24,750, with its median value being -$1,000 (2023).
  • As far as peak fluctuations go, Benitec Biopharma's Other Operating Expenses crashed by 97.92% in 2021, and later surged by 800.00% in 2022.
  • Quarterly analysis of 5 years shows Benitec Biopharma's Other Operating Expenses stood at -$19,000 in 2020, then tumbled by 97.92% to $1,000 in 2021, then skyrocketed by 800.00% to $9,000 in 2022, then reached $1,000 in 2023, then reached -$3,000 in 2024.
  • Its last three reported values are -$3,000 in Q1 2024, $1,000 for Q4 2023, and -$106,000 during Q3 2023.